Imagene Ai Secures $21.5 Million To Push The Boundaries Of Precision Medicine For Cancer
05/02/22, 7:30 AM
Location
Money raised
$21.5 million
Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3 million in seed funding led by Blumberg Capital and an $18.5 million Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura.
Company Info
Location
tel aviv, tel aviv district, israel
Additional Info
” “Imagene is honored to have the support of visionary investors – leaders at the forefront of technology-driven cancer research – who embrace our mission of revolutionizing cancer diagnosis and transforming patient care,” said Dean Bitan, Imagene co-founder and chief executive officer.